Fast antibody responses by immuno-targeting and nanotechnology strategies versus HBsAg vaccine

OBJECTIVE(S): Though immunization with HBsAg has been routine since the 1980s, it has numerous limitations such as low or none humoral immune responses. Today, nanotechnology is used in vaccinology to achieve higher potency. The present study deals with the achievement of fast antibody response of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Mahsa, Hosseini, Seyed Nezamedin, Khavari-Nejad, Ramazan Ali, Najafi, Farhood, Mahdavi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143703/
https://www.ncbi.nlm.nih.gov/pubmed/34094038
http://dx.doi.org/10.22038/IJBMS.2021.52715.11896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143703/
https://www.ncbi.nlm.nih.gov/pubmed/34094038
http://dx.doi.org/10.22038/IJBMS.2021.52715.11896

Ejemplares similares